Madrigal Pharmaceuticals Inc (MDGL) rating upgrades by B. Riley Securities

In a filing, Madrigal Pharmaceuticals Inc revealed its Senior VP, Chief Pharma Dev. Waltermire Robert E. unloaded Company’s shares for reported $0.48 million on Dec 15 ’23. In the deal valued at $238.50 per share,2,000 shares were sold. As a result of this transaction, Waltermire Robert E. now holds 5,667 shares worth roughly $1.61 million. […]

MDGL’s short interest surges to 3.46 million shares

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Madrigal Pharmaceuticals Inc shares valued at $477,000 were sold by Waltermire Robert E. on Dec 15 ’23. At $238.50 per share, Waltermire Robert E. sold 2,000 shares. The insider’s holdings dropped to 5,667 shares […]

Madrigal Pharmaceuticals Inc (MDGL) receives a Buy rating from Citigroup

Madrigal Pharmaceuticals Inc’s recent filing unveils that its Senior VP, Chief Pharma Dev. Waltermire Robert E. unloaded Company’s shares for reported $0.48 million on Dec 15 ’23. In the deal valued at $238.50 per share,2,000 shares were sold. As a result of this transaction, Waltermire Robert E. now holds 5,667 shares worth roughly $1.47 million. […]

A Guide To The Risks Of Investing In Madrigal Pharmaceuticals Inc (MDGL)

Madrigal Pharmaceuticals Inc’s recent filing unveils that its Senior VP, Chief Pharma Dev. Waltermire Robert E. unloaded Company’s shares for reported $0.48 million on Dec 15. In the deal valued at $238.50 per share,2,000 shares were sold. As a result of this transaction, Waltermire Robert E. now holds 5,667 shares worth roughly $1.4 million. Then, […]

MDGL’s short interest shows a sharp rise on Feb 15, 2024

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Madrigal Pharmaceuticals Inc shares valued at $477,000 were sold by Waltermire Robert E. on Dec 15. At $238.50 per share, Waltermire Robert E. sold 2,000 shares. The insider’s holdings dropped to 5,667 shares worth approximately $1.34 million […]

Madrigal Pharmaceuticals Inc (MDGL) receives a Sell rating from B. Riley Securities

Madrigal Pharmaceuticals Inc’s recent filing unveils that its Senior VP, Chief Pharma Dev. Waltermire Robert E. unloaded Company’s shares for reported $0.48 million on Dec 15. In the deal valued at $238.50 per share,2,000 shares were sold. As a result of this transaction, Waltermire Robert E. now holds 5,667 shares worth roughly $1.32 million. Then, […]

Madrigal Pharmaceuticals Inc [NASDAQ: MDGL] Sees Increase in Stock Value

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Madrigal Pharmaceuticals Inc shares valued at $477,000 were sold by Waltermire Robert E. on Dec 15. At $238.50 per share, Waltermire Robert E. sold 2,000 shares. The insider’s holdings dropped to 5,667 shares worth approximately $1.41 million […]

The Attractiveness of Investing In Madrigal Pharmaceuticals Inc (MDGL) is Growing

Madrigal Pharmaceuticals Inc’s recent filing unveils that its Senior VP, Chief Pharma Dev. Waltermire Robert E. unloaded Company’s shares for reported $0.48 million on Dec 15. In the deal valued at $238.50 per share,2,000 shares were sold. As a result of this transaction, Waltermire Robert E. now holds 5,667 shares worth roughly $1.32 million. Then, […]

MDGL Stock Sees Surge of Approximately 15.61% in Last Five Days

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Madrigal Pharmaceuticals Inc shares valued at $477,000 were sold by Waltermire Robert E. on Dec 15. At $238.50 per share, Waltermire Robert E. sold 2,000 shares. The insider’s holdings dropped to […]